SecBot SecBot
DEFA14A ·Filed Apr 10, 2026

KURA

Kura Oncology, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed7mo ago SEC0001193125-26-151363
Proxy solicitation materials
Actionable Insight • Neutral

This is a routine annual meeting with no significant changes or financial implications. Shareholders should review the proxy statement for details on executive compensation and board matters, but no immediate action is required.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$8.72
T+0 close · Apr 10, 2026 · via day close
Latest settled
+38.99%
T+60 · $12.12
Vs SPY
+30.07%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 13 $8.72entry
  2. T+1 · 7mo ago +4.82%α +3.61% · $9.14
  3. T+5 · 7mo ago +12.16%α +8.86% · $9.78
  4. T+20 · 6mo ago +9.06%α +1.33% · $9.51
  5. T+60 · 4mo ago +38.99%α +30.07% · $12.12
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Kura Oncology is holding its annual shareholder meeting to vote on director elections, auditor appointment, executive compensation, and equity plan amendments. This is a routine filing with no material financial impact.

Key Financial Metrics

Vote
director election
Meeting
2026-06-04
Seats Contested
3

Key Facts

  • Kura Oncology is holding its annual shareholder meeting on June 4, 2026
  • Shareholders will vote on the election of three Class III directors
  • The board recommends ratification of Ernst & Young as independent auditors
  • The board recommends approval of executive compensation (Say-on-Pay)
  • The board recommends approval of amendments to the 2014 Equity Incentive Plan and 2015 Employee Stock Purchase Plan

Financial Impact

No material financial impact

Risk Factors

  • None identified - this is a standard annual meeting with no controversial proposals

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001193125-26-151363
Document: 0001193125-26-151363-index-headers.html0001193125-26-151363
Document: 0001193125-26-151363-index.html0001193125-26-151363
Document: 0001193125-26-151363.txt0001193125-26-151363

Track record

29 reports on KURA

Performance horizon

6 of 9 bullish or bearish reports moved the stock their way by T+60. Best: +52.28% at T+60 after the Jun 3, 2026 report. 10 of 14 went positive at some point.

Filters
  1. Nov 16, 2026today Insider Buy Bullish 5/10 Entry $7.15 Now $7.09 −0.84% settles Feb 16
  2. Nov 16, 2026today 144 Neutral 3/10 Entry $7.15 Now $7.09 −0.84% settles Feb 16
  3. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $7.15 Now $7.09 −0.84% settles Feb 16
  4. Nov 10, 20266d ago S-3ASR Neutral 4/10 Entry $7.73 Now $7.09 −8.28% settles Feb 9
  5. Nov 10, 20266d ago Press Release Neutral 5/10 Entry $7.73 Now $7.09 −8.28% settles Feb 9
  6. Nov 4, 202612d ago Press Release Neutral 4/10 Entry $7.61 Now $7.09 −6.83% settles Feb 2
  7. Sep 29, 20266w ago Insider Cluster Bearish 5/10 Entry $10.71 Now $7.09 +33.80% settles Dec 24
  8. Sep 29, 20266w ago Press Release Bullish 6/10 Entry $10.81 Now $7.09 −34.38% settles Dec 23
  9. Sep 9, 20269w ago 8-K Bullish 6/10 Entry $12.09 Now $7.09 −41.36% settles Dec 3
  10. Sep 8, 20269w ago 8-K Neutral 2/10 Entry $12.52 Now $7.09 −43.37% settles Dec 2
Showing 10 of 29

US Market Status

Market Closed · Opens in 6h 53m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 10, 2026